Health-Related Quality of Life in Chronic HCV-Infected Patients Switching to Pegylated-Interferon-Free Regimens (ANRS CO20 CUPIC Cohort Study and SIRIUS Trial)

Autor: Carrieri, Maria Patrizia, Protopopescu, Camelia, Younossi, Zobair, Vilotitch, Antoine, Fontaine, Hélène, Petrov-Sanchez, Ventzislava, Marcellin, Fabienne, Carrat, Fabrice, Hézode, Christophe, Bourlière, Marc, Poncin, Eric, Botta-Friedland, Danièle, Fontanges, Thierry, Arpurt, Jean-Pierre, Bacq, Yannicq, Calès, Paul, Delasalle, Patrick, Ouzan, Denis, Nousbaum, Jean-Baptiste, Sylvain, Christine, Ribard, Didier, Gatineau-Sailliant, Gilles, de Montigny-Lenhardt, Stéphanie, Renard, Philippe, Pilette, Christophe, Denis, Jacques, Lascoux-Combe, Caroline, Abel, Laurent, Albert, Matthew, Chazouillères, Olivier, Dubuisson, Jean, Negro, Francesco, Pageaux, Georges-Philippe, Paradis, Valérie, Spire, Bruno, Taburet, Anne-Marie, Trinchet, Jean-Claude, Yazdanpanah, Yazdan, Dufour, Cécilie, Fréhaut, Céline, Pirot, Marion, Lesel, Aurélie, Zahraa, Nathalie, Chau, Frédéric

Publikováno v: The Patient-Patient-Centered Outcomes Research
The Patient-Patient-Centered Outcomes Research, 2017, 10 (5), pp.605-614. ⟨10.1007/s40271-017-0232-1⟩
The Patient-Patient-Centered Outcomes Research, Vol. 10, No 5 (2017) pp. 605-614

International audience; Objective We aimed to compare health-related quality of life (HRQL) during and after HCV treatment in patients receiving pegylated-interferon (PEG-IFN)-containing therapy (including boceprevir or telaprevir - ANRS CO20 CUPIC c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ff9a9084dace7c7dc34a62f21b4933e
https://hal.science/hal-01767765/document